Rare diseases
Investigational molecules
Locations
Back to Italy2 862 clinical trials in Saronno, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients
ItalyStudy of Immunotherapy Combinations Including Zimberelimab for Patients With Advanced Non-Small Cell Lung Cancer
ItalyStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Moderate to Severe Ulcerative Colitis
ItalyStudy on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment
ItalyStudy of Zipalertinib with Chemotherapy vs. Chemotherapy Alone for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
ItalyStudy on Regorafenib and Pembrolizumab for Patients with Intermediate-Stage Liver Cancer
ItalyStudy of Retifanlimab Alone and in Combination with Drug Therapy for Adults with Advanced or Metastatic Endometrial Cancer Who Have Not Responded to Platinum Chemotherapy
ItalyStudy of Giredestrant, Triptorelin, and Anastrozole in Premenopausal Women with ER-Positive/HER2-Negative Early Breast Cancer
ItalyStudy on [68Ga]Ga-PentixaFor and [18F]FDG PET/CT Imaging for Staging Marginal Zone Lymphoma in Patients with Confirmed Diagnosis
ItalyStudy of Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone for Patients with Newly Diagnosed AL Amyloidosis with Heart Involvement
ItalyStudy on Nalbuphine ER for Treating Cough in Patients with Idiopathic Pulmonary Fibrosis
ItalyStudy on the Long-term Safety and Effects of AL002 and Florquinitau F18 in Patients with Alzheimer's Disease
ItalyThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including studies evaluating novel therapeutic approaches for patients with specific genetic mutations.
Research emphasizes personalized treatment strategies for advanced and metastatic disease states.
Comprehensive studies addressing breast cancer and gynecological malignancies, with focus on treatment timing and maintenance therapies.
Investigations aim to optimize treatment sequences and improve patient outcomes.
Innovative research in renal cell carcinoma treatment and cardiac conditions, particularly focusing on novel therapeutic approaches.
Studies evaluate both oncological interventions and cardiovascular treatments for high-risk patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
